BloodJClub
A single-cell atlas identifies oncogenic transcriptional programs and immune escape mechanisms in CTCL.
Blood · · Journal Article
Wang, Geng + more
Abstract ↗AI summary
The abstract is read at the publisher; the summary is JClub's.
Single-cell RNA sequencing reveals oncogenic transcriptional programs and immune escape mechanisms in over 2 million cells from CTCL patients, highlighting therapeutic vulnerabilities.
- Why it matters: Understanding the transcriptional and microenvironmental landscape of CTCL is crucial to developing more effective, durable treatments for advanced-stage disease, which currently has limited options.
- What they did: The study compiled the largest single-cell atlas of CTCL, analyzing over 2 million skin and blood cells from 116 patients to identify recurrent oncogenic programs and immune cell interactions.
- The result: Findings pinpoint targetable transcriptional pathways and immune components, such as immune checkpoints, enabling the design of combinatorial therapies that exploit these vulnerabilities to improve patient outcomes.
The findingWhy it mattersWhat they didThe result